Randomized controlled trial for TCM syndrome differentiation treatment impacting quality of life of post-discharge patients with novel coronavirus pneumonia (COVID-19)
- Conditions
- ovel Coronavirus Pneumonia (COVID-19)
- Registration Number
- ITMCTR2000003008
- Lead Sponsor
- The First Affiliated Hospital of He'nan University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. General/severe/critical patients who meet the diagnostic criteria of new coronavirus pneumonia;
2. Patients whose viral nucleic acid has turned negative after treatment;
3. Patients who are characterized by respiratory symptoms such as cough, shortness of breath, chest tightness or corresponding chest imaging features;
4. Patients who meet TCM syndrome;
5. Patients who voluntarily participate in the study and sign informed consent.
1. Patients with cognitive disorder or known mental illness;
2. Pregnant or lactating women;
3. Patients with active tuberculosis, pulmonary abscess or chronic respiratory failure;
4. Patients with tumor;
5. Patients with severe liver or kidney diseases;
6. Patients with severe cardiovascular or cerebrovascular diseases;
7. Patients who are participating in clinical trials of other drugs, or known to be allergic to therapeutic drugs.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.